4D Molecular Therapeutics (FDMT) Change in Acquisitions & Divestments (2021 - 2025)

4D Molecular Therapeutics (FDMT) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $49.2 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 25.24% to $49.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $350.4 million through Dec 2025, up 107.33% year-over-year, with the annual reading at $350.4 million for FY2025, 107.33% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $49.2 million at 4D Molecular Therapeutics, up from $32.9 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $205.3 million in Q3 2022, with the low at -$135.2 million in Q4 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $49.7 million, with a median of $49.2 million recorded in 2025.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 2803.88% in 2022, then soared 1027.88% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $5.0 million in 2021, then crashed by 2803.88% to -$135.2 million in 2022, then surged by 121.09% to $28.5 million in 2023, then soared by 130.72% to $65.8 million in 2024, then decreased by 25.24% to $49.2 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $49.2 million, $32.9 million, and $101.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.